We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$456M
AUM Growth
+$2.09M
Cap. Flow
-$9.77M
Cap. Flow %
-2.14%
Top 10 Hldgs %
14.03%
Holding
362
New
46
Increased
61
Reduced
100
Closed
43

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.2M
2
IVZ icon
Invesco
IVZ
+$3.16M
3
DELL icon
Dell
DELL
+$2.9M
4
PFE icon
Pfizer
PFE
+$2.83M
5
JNPR
Juniper Networks
JNPR
+$2.44M

Top Sells

Rank Stock Value
1
MDP
Meredith Corporation
MDP
+$2.9M
2
VIVO
Meridian Bioscience Inc
VIVO
+$2.77M
3
CLFD icon
Clearfield
CLFD
+$2.59M
4
QCOM icon
Qualcomm
QCOM
+$2.5M
5
TRTN
Triton International Limited
TRTN
+$2.42M

Sector Composition

Rank Sector Weight
1 Healthcare 15.25%
2 Consumer Discretionary 14.74%
3 Materials 12.22%
4 Technology 12.17%
5 Consumer Staples 10.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGI
201
Somnigroup International
SGI
$13.6B
$734K 0.16%
15,600
– –
CFG icon
202
Citizens Financial Group
CFG
$30.5B
$732K 0.16%
15,500
– –
CPE
203
DELISTED
Callon Petroleum Company
CPE
$732K 0.16%
15,500
– –
JKS
204
JinkoSolar
JKS
$847M
$717K 0.16%
15,600
-46,400
-75% -$2.4M
MD icon
205
Pediatrix Medical
MD
$2.15B
$707K 0.16%
+26,000
New +$696K
ABBV icon
206
AbbVie
ABBV
$431B
$704K 0.15%
5,200
-7,200
-58% -$851K
VTRS icon
207
Viatris
VTRS
$19B
$704K 0.15%
52,000
-41,000
-44% -$547K
ASB icon
208
Associated Banc-Corp
ASB
$5.88B
$700K 0.15%
31,000
– –
JLL icon
209
Jones Lang LaSalle
JLL
$16.7B
$700K 0.15%
2,600
-1,000
-28% -$258K
POLY
210
DELISTED
Plantronics, Inc.
POLY
$692K 0.15%
23,600
-5,200
-18% -$144K
EVH icon
211
Evolent Health
EVH
$404M
$686K 0.15%
24,800
– –
NMIH icon
212
NMI Holdings
NMIH
$3.31B
$677K 0.15%
31,000
– –
FDX icon
213
FedEx
FDX
$74.7B
$672K 0.15%
2,600
-6,700
-72% -$1.61M
VRA icon
214
Vera Bradley
VRA
$96.1M
$664K 0.15%
78,000
+31,500
+68% +$303K
TDC icon
215
Teradata
TDC
$2.54B
$663K 0.15%
+15,600
New +$770K
DBI icon
216
Designer Brands
DBI
$336M
$661K 0.15%
46,500
– –
VIR icon
217
Vir Biotechnology
VIR
$1.48B
$653K 0.14%
+15,600
New +$611K
AZO icon
218
AutoZone
AZO
$50.1B
$650K 0.14%
310
– –
FFIV icon
219
F5
FFIV
$23.5B
$636K 0.14%
2,600
-9,800
-79% -$2.18M
GEF icon
220
Greif
GEF
$5.07B
$628K 0.14%
+10,400
New +$674K
PRIM icon
221
Primoris Services
PRIM
$4.35B
$623K 0.14%
26,000
-51,500
-66% -$1.3M
FLWS icon
222
1-800-Flowers.com
FLWS
$258M
$608K 0.13%
+26,000
New +$755K
EXAS
223
DELISTED
Exact Sciences
EXAS
$607K 0.13%
7,800
-1,500
-16% -$132K
LEN icon
224
Lennar Class A
LEN
$20.4B
$604K 0.13%
5,372
-4,235
-44% -$433K
HP icon
225
Helmerich & Payne
HP
$3.7B
$592K 0.13%
25,000
– –
7 8
9
10 11

Similar funds

FGP
Foyston, Gordon, & Payne Toronto, Ontario, Canada $434M AUM 9.09% 1-Year Est. Return
HCM
Horiko Capital Management New York $434M AUM 47.96% 1-Year Est. Return
JWM
JPL Wealth Management Highlands Ranch, Colorado $435M AUM 16.48% 1-Year Est. Return
GDS
Gimbel Daniel Scott $435M AUM 78.68% 1-Year Est. Return
IA
Icon Advisers Greenwood Village, Colorado $433M AUM 40.01% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VDBMI
Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

Hussman Strategic Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Hussman Strategic Advisors held 362 positions worth $456M, up 0.46% from $454M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Hussman Strategic Advisors's Q4 2021 filing shows 46 new, 61 increased, 100 reduced and 43 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 5,200 shares worth $3.28M. The largest sale was Meredith Corporation, an estimated $2.9M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Materials.

  • Hussman Strategic Advisors's largest Q4 2021 buy was Regeneron Pharmaceuticals: 5,200 shares worth $3.28M.
  • Hussman Strategic Advisors added most to Newmont in Q4 2021, an estimated $2.27M increase.
  • Hussman Strategic Advisors's biggest Q4 2021 reduction was Clearfield, cutting an estimated $2.59M.
  • Hussman Strategic Advisors fully exited Meredith Corporation in Q4 2021, selling an estimated $2.9M.
  • Hussman Strategic Advisors's ten largest holdings make up 14% of its $456M portfolio in Q4 2021.
  • Hussman Strategic Advisors opened 46 new positions and closed 43 in Q4 2021.
  • Hussman Strategic Advisors's portfolio value rose 0.46% quarter-over-quarter to $456M.

Based on Hussman Strategic Advisors's 13F filing for Q4 2021, filed 31 Jan 2022.